Respiratory diagnostic devices market seen reaching $13.29 billion by 2030

The Business Research Company says the global market for respiratory diagnostic devices and equipment will grow from $8.36 billion in 2025 to $13.29 billion by 2030. Rising respiratory disease rates, home monitoring demand and broader use of molecular and imaging tests are driving the outlook.

Why it matters: - Respiratory diagnostic devices help detect and manage asthma, cystic fibrosis and chronic obstructive pulmonary disease. - The market forecast points to rising demand for tools that measure lung function and oxygen levels as respiratory disease remains a global health burden. - Faster diagnosis and more home-based monitoring could change how patients are screened and followed over time.

What happened: - The Business Research Company published a new report on the respiratory devices and equipment (diagnostic) market on Aug. 28, 2026. - The market is projected to increase from $8.36 billion in 2025 to $9.18 billion in 2026. - The report forecasts the market will reach $13.29 billion by 2030. - The forecast implies a 9.8% CAGR from 2025 to 2026 and a 9.7% CAGR through 2030. - The company also offered a free sample of the report and the full market report.

The details: - The report ties recent growth to higher rates of respiratory illness, more pulmonary diagnostic labs, stronger demand for early diagnosis, wider availability of advanced spirometry equipment and greater use of oxygen monitoring devices. - Future growth drivers include more investment in respiratory diagnostics, broader adoption of molecular and imaging tests, expansion of home-based monitoring, a stronger focus on personalized respiratory treatment and continued innovation in diagnostic assays. - Expected trends include more portable diagnostic tools, greater reliance on molecular testing for respiratory diseases, use of artificial intelligence in lung function analysis, growth in point-of-care respiratory diagnostics and more emphasis on early disease detection. - World Health Organization data cited in the report showed 81.7 million people were living with chronic respiratory diseases in June 2025, with 6.8 million new cases diagnosed each year. - The report describes respiratory diagnostic devices as tools used to identify and monitor conditions that affect breathing and oxygen exchange.

Between the lines: - The report points to a shift from traditional hospital-based testing toward more portable, point-of-care and home-based diagnostics. - Artificial intelligence in lung function analysis suggests respiratory testing is becoming more data-driven, not just more accessible. - Asia-Pacific led the market in 2025, with North America ranked second, which signals where demand and commercial activity are most concentrated.

What's next: - The Business Research Company expects continued double-digit-style growth momentum to carry the market through 2030. - The report highlights ongoing innovation in diagnostic assays and broader use of molecular testing as the main near-term catalysts. - The company’s 2026 report package also includes market attractiveness scoring, TAM analysis, a company scoring matrix, Excel-based forecasting dashboards, hotspots infographics and updated graphics and tables.

The bottom line: - Respiratory diagnostics is positioned for steady expansion as disease prevalence rises and testing moves closer to the patient.